FTLP18

Across TCGA pan-cancer cohorts, FTLP18 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated FTLP18 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher FTLP18 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FTLP18 expression acts as an unfavorable survival marker.

LUAD, THCA, and UCEC are the cancer types where FTLP18 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.045	0.717	<.001	90	view →
THCA	DFS	Tertile	II,III,IV	0.146	0.869	<.001	54	view →
UCEC	OS	Tertile	All	0.792	0.930	<.001	42	view →
READ	OS	Tertile	III,IV	0.330	0.900	<.001	36	view →
CESC	OS	Tertile	All	0.261	0.798	.009	18	view →
PCPG	DFS	Tertile	All	0.535	0.924	<.001	18	view →
SKCM	DFS	Tertile	All	0.345	0.622	.035	12	view →
MESO	DFS	Tertile	III,IV	0.171	0.418	.046	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
LGG	OS	Tertile	All	0.640	0.814	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

FTLP18–LUAD (DFS)

Open the LUAD breakdown →